Form4insider filings, from the source

SEC Form 4/A · accession 0001209191-15-047279

Revance Therapeutics, Inc. · RVNC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Jonathan Tunnicliffe
Director · 10% Owner
Period of report
May 7, 2015
Accepted (ET)
May 27, 2015 · 8:33 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001479290

Table I — non-derivative securities

No Table I lines on this filing.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F2,F1$20.42May 7, 2015A8,000A—May 6, 2025Common Stock8,0008,000D

Explanation of responses

Remarks

The purpose of this amendment is to include footnote 2 describing the form of ownership of stock option in Table II, Column 10, which was inadvertently omitted from the Reporting Person's original Form 4.